DTN-UK Webinar - Update and discussion of current position of the HCL rollout

Geraldine Gallen is a Senior Diabetes Specialist Nurse, currently working at Kings College Hospital, London. She has been in this position for over ten years and is the lead for the Type 1 diabetes service. Geraldine’s main clinical interest is in the management and education of all patients with Type 1 diabetes including those patients experiencing problematic hypoglycaemia, and along with the team at Kings offers a full range of treatments including structured education, DAFNE and DAFNE for pumpers, technology including insulin pump therapy, sensor augmented pump therapy, automated closed loop systems, continuous glucose monitoring and flash glucose monitoring.

She and her team have over 800 patients on insulin pumps and over 170 patients funded on full time continuous glucose monitoring. Geraldine has also had training in Cognitive Behavioural therapy (CBT) and Motivational Interviewing (MI) and is interested in developing these skills further and supporting patients in their holistic management with their diabetes. Geraldine is excited by the developments of technology within type 1 diabetes management and can often be found talking to patients and healthcare professionals nationally and internationally educating how technology can be adapted into the patient pathway.

Dr Sufyan Hussain is a Medical Research Council-funded clinician scientist working as a Diabetes Physician at Guy’s and St Thomas Hospital and an Honorary Reader in Diabetes at King’s College London. He has a specialist clinical and research interest in the application of diabetes technologies and novel therapies, including cell therapy, in type 1 diabetes. He graduated from the University of Cambridge and undertook specialist training in London. He completed his PhD at Imperial College London and was a visiting scholar at Joslin Diabetes Centre, Harvard Medical School. He was the lead clinical expert on the landmark NICE Technology appraisal for hybrid-closed loop systems in type 1 diabetes in England. He currently serves as a vice-chair of the UK’s Association of British Clinical Diabetologist’s Diabetes Technology Network and board of directors for the International Diabetes Federation- Europe. He has over 30 years of personal experience living with type 1 diabetes and is passionate about improving diabetes care.